Related Experiment Video
Updated: Feb 15, 2026

A Patient-Derived Xenograft Model for Venous Malformation
Published on: June 15, 2020
An institution-wide algorithm for direct-stick embolization of peripheral venous malformations
Naiem Nassiri1, Lauren A Huntress2, Mitchell Simon3
1Division of Vascular and Endovascular Surgery, Department of Surgery, Yale University School of Medicine and Yale New Haven Hospital, New Haven, Conn.
This study shows that direct-stick embolization with sodium tetradecyl sulfate (STS) is a safe and effective treatment for congenital peripheral venous malformations (VMs). Most patients achieved symptom relief after a single session, avoiding ethanol toxicity.
Area of Science:
- Vascular Surgery
- Interventional Radiology
- Dermatology
Background:
- Congenital peripheral venous malformations (VMs) lack standardized treatment algorithms, leading to varied outcomes.
- Current management options and embolic agents for VMs are not uniform.
- This study addresses the need for a consistent approach to managing symptomatic VMs.
Purpose of the Study:
- To present an institution-wide algorithm for managing symptomatic congenital peripheral VMs.
- To evaluate the efficacy and safety of a single embolotherapeutic agent for VM treatment.
- To establish a standardized protocol for VM embolization.
Main Methods:
- A 36-month retrospective review of patients with symptomatic congenital peripheral VMs treated with a specific algorithm.
- Utilized contrast-enhanced MRI, venous duplex ultrasound, and hematologic monitoring.
- Embolization performed using direct-stick technique with two concentrations of sodium tetradecyl sulfate (STS).
Main Results:
- 71 direct-stick embolizations (DSEs) were performed in 40 patients over 36 months.
- 65% of patients experienced complete symptom relief after a single DSE session.
- The primary complications were skin necrosis (3%), with one case of fatal pulmonary embolism (1.4%).
Conclusions:
- Liquid sodium tetradecyl sulfate (STS) is a safe embolotherapeutic agent for congenital peripheral VMs, avoiding ethanol-related toxicity.
- Venous thromboembolism remains a significant risk despite careful monitoring.
- Further prospective randomized trials are necessary to standardize embolotherapeutic approaches for VMs.
Related Concept Videos
Pulmonary Embolism I: Introduction
Trial and Error and Algorithm
Venous Return
What is Venous Return?
Venous return refers to the rate at which blood flows back to the heart from the body's peripheral veins. It's an integral part of the circulatory system...
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management
Directing Effect of Substituents: meta-Directing Groups

